Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Pharmacokinetics of lj-2698, a potent human a3 adenosine receptor antagonist, in rats
- At: 2017 FIP Congress in Seoul (South Korea)
- Type: Poster
- By: KIM, Dae-Duk (Seoul National University, College of Pharmacy, Seoul, Korea, Republic Of)
- Co-author(s): Jae-Young Lee
Lak Shin Jeong
BackgroundLJ-2698 is a highly potent human A3 adenosine receptor (hA3 AR) antagonist with nucleoside structure, which was designed to have a minimal species dependence. While there is relatively abundant information on the pharmacological activities of A3 AR agonists/antagonists, their pharmacokinetic properties have not been reported.
PurposeLiquid.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019